Claims

VIST endovascular simulator training transferred to real-world performance, with improved technical skill metrics on real patients (LoE 3/5)

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2022 · not yet checked against its sources · not reviewed by a person

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? The Vascular Intervention System Trainer (VIST), validated by 15 studies, showed transfer to clinical practice: practicing iliofemoral and superficial femoral angioplasty on VIST improved technical skill metrics and translated to real-world performance (LoE 3/5). → Haiser Alexander 2022

Evidence

Haiser Alexander 2022

Haiser Alexander, Aydin Abdullatif, Kunduzi Basir, Ahmed Kamran, Dasgupta Prokar. (2022). A Systematic Review of Simulation-Based Training in Vascular Surgery. The Journal of Surgical Research. https://doi.org/10.1016/j.jss.2022.05.009

q2 · i? · review · r2

Review narrative of VIST validation studies. Chaer et al. was a randomized, controlled study per the reference list, and Hseino et al. found practicing superior femoral angioplasty on VIST "translated to real-world performance". Most VIST studies scored LoE 1-2/5.

"Chaer et al. used VIST to trial a simulated iliofemoral angioplasty and found an improvement in all technical skill metrics when later performed on real patients (LoE = 3/5)."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-31
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.